Simon Dixon - Publications 

Journal articles

Conference proceedings papers

  • Brennan VK, Dixon S, Jones G, Radley S, Jacques R, Wood H & Ledger W (2013) AN ECONOMIC EVALUATION ALONGSIDE A CLINICAL TRIAL (EEACT) IN PELVIC FLOOR MEDICINE. VALUE IN HEALTH, Vol. 16(7) (pp A334-A334)
  • Jones GL, Radley S, Dixon S, Jacques R, Brennan V, Wood H & Ledger W (2013) Evaluating the impact of a 'virtual clinic' on the quality and cost of patient care in urogynaecology: an RCT. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 120 (pp 287-288)
  • Thokala P, Baalbaki H, Lowrie K, Dixon S & Brennan A (2013) Financial modelling for telemonitoring. INTERNATIONAL JOURNAL OF INTEGRATED CARE, Vol. 13
  • Brennan VK & Dixon S (2012) A LITERATURE REVIEW OF EMPIRICAL STUDIES OF PROCESS UTILITY. VALUE IN HEALTH, Vol. 15(4) (pp A165-A165)
  • Dixon S, Retsa P, Odeyemi I, Chambers C & Currie CJ (2010) Evaluation of health-related utility values for pain states characterised by the Numeric Pain Rating Scale established using a time trade-off method. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 17 (pp 294-294)
  • Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K & Davies MJ (2009) Cost effectiveness of the DESMOND structured education programme for patients newly diagnosed with type 2 diabetes. DIABETOLOGIA, Vol. 52 (pp S12-S12)
  • Brugha T, Morrell J, Dixon S, Walters S & Slade P (2009) Prevention of Postnatal Depression: Cost-Effectiveness of Health Visitor Training; Results from a Cluster Randomised Controlled Trial in Primary Care. J MENT HEALTH POLICY, Vol. 12 (pp S8-S8)
  • Conway P, Dixon S & Currie CJ (2008) EVALUATION OF TREATMENT SATISFACTION WITH ETANERCEPT VERSUS ALTERNATIVE TREATMENTS FOR PSORIASIS: A PATIENT SURVEY ACROSS NINE EUROPEAN COUNTRIES. VALUE HEALTH, Vol. 11(6) (pp A626-A626)
  • Slade P, Morrell L, Walters SJ, Dixon S, Brugha T, Paley G, Wamer R & Mathers N (2007) The ponder trial: A cost-effectiveness trial of psychological intervention by health visitors for postnatal depression. J PSYCHOSOM OBST GYN, Vol. 28 (pp 64-64)
  • Briggs A, Nixon R, Dixon S & Thompson S (2005) Parametric modelling of cost data: some simulation evidence. HEALTH ECONOMICS, Vol. 14(4) (pp 421-428)
  • Currie CJ, Dixon S, Conway P & McEwan P (2004) Evaluation of the cost utility of sirolimus versus tacrolimus for immunosuppression for renal transplantation in the United Kingdom. VALUE HEALTH, Vol. 7(6) (pp 800-800)
  • Moore AP, Lloyd A, Scott DA, Connolly M & Dixon S (2004) The cost-effectiveness of treating patients with restless legs syndrome (RLS) using ropinirole. VALUE HEALTH, Vol. 7(6) (pp 791-791)
  • Moore AP, Lloyd A, Scott D, Connolly MP & Dixon S (2004) The cost-effectiveness of treating patients with restless legs syndrome (RLS) using ropinirole. EUR J NEUROL, Vol. 11 (pp 116-116)
  • Morrell CJ, Warner R, Mathers N, Parry G, Dixon S, Slade P, Mcguirk E, Paley G & Brugha T (2004) PoNDER: PostNatal Depression Economic Evaluation and Randomised Trial. J REPROD INFANT PSYC, Vol. 22(3) (pp 236-236)
  • McEwan P, Morrissey M, Peters JR, Dixon S, Farina C & Currie CJ (2004) Evaluation of the association between heath-related utility and obesity in hospital-treated subjects. INTERNATIONAL JOURNAL OF OBESITY, Vol. 28 (pp S124-S124)
  • Dixon S, McEwan P & Currie CJ (2004) Including carer utility in economic evaluations: A preliminary analysis of the implications for funding thresholds. VALUE HEALTH, Vol. 7(3) (pp 371-371)
  • Currie CJ, Dixon S, Morrissey M, Farina C, Peters JR & McEwan P (2004) Evaluation of the association between health-related utility and obesity in hospital treated subjects. VALUE HEALTH, Vol. 7(3) (pp 331-331)
  • McEwan P, Kind P, Dixon S & Currie CJ (2004) Using an artificial neural network to predict utility scores from SF-36 data. VALUE HEALTH, Vol. 7(3) (pp 305-305)
  • Dixon S, Morrissey MI, Patel TC, Home PD, Peters JR, Bearne A, Sharplin P, Davies S & Currie CJ (2002) The interaction between frequency of hypoglycaemia, single and multiplevascular complications and health utility. DIABETOLOGIA, Vol. 45 (pp A101-A101)
  • Hancock BW, Dixon S, Turner LA, Wheatley K, Ives N & Gore M (2002) Aim high - Adjuvant interferon in melanoma (high risk): The costs.. BRIT J CANCER, Vol. 86 (pp S27-S28)

Other

  • Dixon S, Rotherham G, Whitfield M & Green C (2000) Evaluation of effect of changes is essential in policymaking. BRIT MED J, 320(7233), 516-516.
  • Dixon S & Green C (1999) Measuring outcomes in economic evaluations - This economics note is misleading. BRIT MED J, 319(7211), 705-705.
  • Dixon S, Green C & Torgerson DJ (1999) Measuring outcomes in economic evaluations (multiple letters) [2]. British Medical Journal, 319(7211), 705-706.